Biogen Inc. buy Truist Financial Co.
Start price
16.05.24
/
50%
€210.90
Target price
16.05.25
€312.83
Performance (%)
-19.42%
Price
25.09.24
€169.95
Summary
This prediction is currently active. The price of Biogen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.42%. This prediction currently runs until 16.05.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -4.442% | -4.442% |
iShares Core DAX® | 0.936% | 1.535% |
iShares Nasdaq 100 | 3.064% | 1.968% |
iShares Nikkei 225® | 1.898% | -0.295% |
iShares S&P 500 | 1.653% | 2.318% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $340.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat